Home LiteratureArticle Details
PMID: 8230453 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Epstein-Barr virus recombinants from overlapping cosmid fragments.

Journal of virology ·Vol. 67 ·No. 12 ·1993-12-00 ·Pages 7298-306

Tomkinson B, Robertson E, Yalamanchili R, Longnecker R, Kieff E

Abstract

Five overlapping type 1 Epstein-Barr virus (EBV) DNA fragments constituting a complete replication- and transformation-competent genome were cloned into cosmids and transfected together into P3HR-1 cells, along with a plasmid encoding the Z immediate-early activator of EBV replication. P3HR-1 cells harbor a type 2 EBV which is unable to transform primary B lymphocytes because of a deletion of DNA encoding EBNA LP and EBNA 2, but the P3HR-1 EBV can provide replication functions in trans and can recombine with the transfected cosmids. EBV recombinants which have the type 1 EBNA LP and 2 genes from the transfected EcoRI-A cosmid DNA were selectively and clonally recovered by exploiting the unique ability of the recombinants to transform primary B lymphocytes into lymphoblastoid cell lines. PCR and immunoblot analyses for seven distinguishing markers of the type 1 transfected DNAs identified cell lines infected with EBV recombinants which had incorporated EBV DNA fragments beyond the transformation marker-rescuing EcoRI-A fragment. Approximately 10% of the transforming virus recombinants had markers mapping at 7, 46 to 52, 93 to 100, 108 to 110, 122, and 152 kbp from the 172-kbp transfected genome. These recombinants probably result from recombination among the transfected cosmid-cloned EBV DNA fragments. The one recombinant virus examined in detail by Southern blot analysis has all the polymorphisms characteristic of the transfected type 1 cosmid DNA and none characteristic of the type 2 P3HR-1 EBV DNA. This recombinant was wild type in primary B-lymphocyte infection, growth transformation, and lytic replication. Overall, the type 1 EBNA 3A gene was incorporated into 26% of the transformation marker-rescued recombinants, a frequency which was considerably higher than that observed in previous experiments with two-cosmid EBV DNA cotransfections into P3HR-1 cells (B. Tomkinson and E. Kieff, J. Virol. 66:780-789, 1992). Of the recombinants which had incorporated the marker-rescuing cosmid DNA fragment and the fragment encoding the type 1 EBNA 3A gene, most had incorporated markers from at least two other transfected cosmid DNA fragments, indicating a propensity for multiple homologous recombinations. The frequency of incorporation of the nonselected transfected type 1 EBNA 3C gene, which is near the end of two of the transfected cosmids, was 26% overall, versus 3% in previous experiments using transfections with two EBV DNA cosmids. In contrast, the frequency of incorporation of a 12-kb EBV DNA deletion which was near the end of two of the transfected cosmids was only 13%.(ABSTRACT TRUNCATED AT 400 WORDS)

MeSH Terms
Antigens, Viral/genetics Cell Transformation, Viral Cells, Cultured Cosmids/genetics DNA-Binding Proteins/genetics Defective Viruses/genetics Epstein-Barr Virus Nuclear Antigens Escherichia coli/genetics Gene Library Genetic Markers Genome, Viral Herpesvirus 4, Human/genetics Humans Recombination, Genetic Transfection
Chemicals
Antigens, Viral DNA-Binding Proteins Epstein-Barr Virus Nuclear Antigens Genetic Markers
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Tomkinson B
Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115.
Robertson E
Yalamanchili R
Longnecker R
Kieff E
References (48)
48 references, click to expand
  1. Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, other head and neck neoplasms, and control groups.
    J Natl Cancer Inst. 1970 Jan;44(1):225-31 PMID: 11515035
  2. Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation.
    Proc Natl Acad Sci U S A. 1993 Oct 1;90(19):9150-4 PMID: 8415670
  3. Cultivation and fine structure of virus-bearing lymphoblasts from a second New Guinea Burkitt lymphoma: establishment of sublines with unusual cultural properties.
    Int J Cancer. 1968 Mar 15;3(2):171-82 PMID: 5649156
  4. Relation of Burkitt's tumor-associated herpes-ytpe virus to infectious mononucleosis.
    Proc Natl Acad Sci U S A. 1968 Jan;59(1):94-101 PMID: 5242134
  5. EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx.
    Nature. 1970 Dec 12;228(5276):1056-8 PMID: 4320657
  6. The establishment of lymphoblastoid lines from adult and fetal human lymphoid tissue and its dependence on EBV.
    Int J Cancer. 1971 Nov 15;8(3):443-50 PMID: 4332899
  7. Epstein-Barr virus: transformation, cytopathic changes, and viral antigens in squirrel monkey and marmoset leukocytes.
    Proc Natl Acad Sci U S A. 1972 Feb;69(2):383-7 PMID: 4333982
  8. Release of infectious Epstein-Barr virus by transformed marmoset leukocytes.
    Proc Natl Acad Sci U S A. 1973 Jan;70(1):190-4 PMID: 4346033
  9. Malignant lymphoma in cottontop marmosets after inoculation with Epstein-Barr virus.
    Proc Natl Acad Sci U S A. 1973 Sep;70(9):2487-91 PMID: 4354852
  10. Differences between laboratory strains of Epstein-Barr virus based on immortalization, abortive infection, and interference.
    Proc Natl Acad Sci U S A. 1974 Oct;71(10):4006-10 PMID: 4372601
  11. Nasopharyngeal carcinoma. X. Presence of epstein-barr genomes in separated epithelial cells of tumours in patients from Singapore, Tunisia and Kenya.
    Int J Cancer. 1975 Jul 15;16(1):7-15 PMID: 170215
  12. Physical mapping of herpes simplex virus type 1 mutations by marker rescue.
    J Virol. 1978 Oct;28(1):182-92 PMID: 212602
  13. Transformation of mammalian cells with genes from procaryotes and eucaryotes.
    Cell. 1979 Apr;16(4):777-85 PMID: 222468
  14. DNA of Epstein-Barr virus VIII: B95-8, the previous prototype, is an unusual deletion derivative.
    Cell. 1980 Nov;22(1 Pt 1):257-67 PMID: 6253079
  15. Epstein-Barr virus DNA. IX. Variation among viral DNAs from producer and nonproducer infected cells.
    J Virol. 1981 May;38(2):632-48 PMID: 6264134
  16. A generalized technique for deletion of specific genes in large genomes: alpha gene 22 of herpes simplex virus 1 is not essential for growth.
    Cell. 1981 Jul;25(1):227-32 PMID: 6268303
  17. Characteristics of Epstein-Barr virus activation of human B lymphocytes.
    J Exp Med. 1981 Sep 1;154(3):832-9 PMID: 6268732
  18. New Epstein-Barr virus variants from cellular subclones of P3J-HR-1 Burkitt lymphoma.
    Nature. 1982 Jan 14;295(5845):160-3 PMID: 6276755
  19. Epstein-Barr virus DNA XII. A variable region of the Epstein-Barr virus genome is included in the P3HR-1 deletion.
    J Virol. 1982 Sep;43(3):979-86 PMID: 6292475
  20. Non-immortalizing P3J-HR-1 Epstein-Barr virus: a deletion mutant of its transforming parent, Jijoye.
    J Virol. 1982 Dec;44(3):834-44 PMID: 6294333
  21. Organization of the Epstein-Barr virus DNA molecule. III. Location of the P3HR-1 deletion junction and characterization of the NotI repeat units that form part of the template for an abundant 12-O-tetradecanoylphorbol-13-acetate-induced mRNA transcript.
    J Virol. 1983 Oct;48(1):135-48 PMID: 6310141
  22. Replication of Epstein-Barr virus in human epithelial cells infected in vitro.
    Nature. 1983 Dec 1-7;306(5942):480-3 PMID: 6316160
  23. DNA sequence and expression of the B95-8 Epstein-Barr virus genome.
    Nature. 1984 Jul 19-25;310(5974):207-11 PMID: 6087149
  24. Transformation by Epstein-Barr virus requires DNA sequences in the region of BamHI fragments Y and H.
    J Virol. 1985 Aug;55(2):286-97 PMID: 2991556
  25. Polymorphic proteins encoded within BZLF1 of defective and standard Epstein-Barr viruses disrupt latency.
    J Virol. 1987 Dec;61(12):3672-9 PMID: 2824806
  26. Randomly picked cosmid clones overlap the pyrB and oriC gap in the physical map of the E. coli chromosome.
    Nucleic Acids Res. 1988 Mar 25;16(6):2601-12 PMID: 2834694
  27. Regeneration of herpesviruses from molecularly cloned subgenomic fragments.
    J Virol. 1988 Jun;62(6):2191-5 PMID: 2835520
  28. A survey of Epstein-Barr virus DNA in lymphoid tissue. Frequent detection in Hodgkin's disease.
    Am J Clin Pathol. 1989 Jan;91(1):1-5 PMID: 2535912
  29. Two families of sequences in the small RNA-encoding region of Epstein-Barr virus (EBV) correlate with EBV types A and B.
    J Virol. 1989 Feb;63(2):983-6 PMID: 2536122
  30. Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes.
    Nature. 1989 Aug 3;340(6232):393-7 PMID: 2547164
  31. Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease.
    N Engl J Med. 1989 Oct 19;321(16):1080-5 PMID: 2552313
  32. Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation.
    Proc Natl Acad Sci U S A. 1989 Dec;86(23):9558-62 PMID: 2556717
  33. Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes.
    J Virol. 1990 Sep;64(9):4084-92 PMID: 2166806
  34. Recombinant Epstein-Barr virus with small RNA (EBER) genes deleted transforms lymphocytes and replicates in vitro.
    Proc Natl Acad Sci U S A. 1991 Feb 15;88(4):1546-50 PMID: 1847527
  35. Epstein-Barr virus (EBV) recombinants: use of positive selection markers to rescue mutants in EBV-negative B-lymphoma cells.
    J Virol. 1991 Apr;65(4):1701-9 PMID: 1848303
  36. Epstein-Barr virus nuclear protein 2 mutations define essential domains for transformation and transactivation.
    J Virol. 1991 May;65(5):2545-54 PMID: 1850028
  37. BHRF1, the Epstein-Barr virus gene with homology to Bc12, is dispensable for B-lymphocyte transformation and virus replication.
    J Virol. 1991 Nov;65(11):5991-6000 PMID: 1656084
  38. The Epstein-Barr virus nuclear protein encoded by the leader of the EBNA RNAs is important in B-lymphocyte transformation.
    J Virol. 1991 Dec;65(12):6826-37 PMID: 1658376
  39. Second-site homologous recombination in Epstein-Barr virus: insertion of type 1 EBNA 3 genes in place of type 2 has no effect on in vitro infection.
    J Virol. 1992 Feb;66(2):780-9 PMID: 1309912
  40. BHRF1 of Epstein-Barr virus, which is homologous to human proto-oncogene bcl2, is not essential for transformation of B cells or for virus replication in vitro.
    J Virol. 1992 Apr;66(4):1899-906 PMID: 1312610
  41. Use of second-site homologous recombination to demonstrate that Epstein-Barr virus nuclear protein 3B is not important for lymphocyte infection or growth transformation in vitro.
    J Virol. 1992 May;66(5):2893-903 PMID: 1313908
  42. A selectable marker allows investigation of a nontransforming Epstein-Barr virus mutant.
    J Virol. 1992 May;66(5):3214-9 PMID: 1313925
  43. Targeted gene disruption in Epstein-Barr virus.
    Virology. 1992 Jul;189(1):253-65 PMID: 1318603
  44. Epstein-Barr virus (EBV)-negative B-lymphoma cell lines for clonal isolation and replication of EBV recombinants.
    J Virol. 1992 Aug;66(8):4972-81 PMID: 1321281
  45. Marker rescue of a transformation-negative Epstein-Barr virus recombinant from an infected Burkitt lymphoma cell line: a method useful for analysis of genes essential for transformation.
    J Virol. 1993 Jan;67(1):606-9 PMID: 8380096
  46. The last seven transmembrane and carboxy-terminal cytoplasmic domains of Epstein-Barr virus latent membrane protein 2 (LMP2) are dispensable for lymphocyte infection and growth transformation in vitro.
    J Virol. 1993 Apr;67(4):2006-13 PMID: 8383224
  47. Epstein-Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocyte growth transformation.
    J Virol. 1993 Apr;67(4):2014-25 PMID: 8445720
  48. Herpes-type virus and chromosome marker in normal leukocytes after growth with irradiated Burkitt cells.
    Science. 1967 Sep 1;157(3792):1064-5 PMID: 6036237
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
1993-12-00
Pages
7298-306
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC238193
Subset
IM
Grants
NCI NIH HHS · NCI CA47006 · United States
NIAID NIH HHS · NIAID AI08548-02 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]